23858 Federal Register / Vol. 87, No. 77 / Thursday, April 21, 2022 / Notices 

Dated: April 15, 2022. 

Alexa Cole, 

Director, Office of International Affairs, 

Trade, and Commerce, National Marine 

Fisheries Service. 

[FR Doc. 2022–08477 Filed 4–20–22; 8:45 am] 

BILLING CODE 3510–22–P 

DEPARTMENT OF COMMERCE 

Patent and Trademark Office 

[Docket No. PTO–P–2022–0016] 

Grant of Interim Extension of the Term 

of U.S. Patent No. 9,364,354; Reducer®

AGENCY: United States Patent and 

Trademark Office, Department of 

Commerce. 

ACTION: Notice of Interim Patent Term 

Extension. 

SUMMARY: The United States Patent and 

Trademark Office has issued an order 

granting interim extension for a oneyear interim extension of the term of 

U.S. Patent No. 9,364,354. 

FOR FURTHER INFORMATION CONTACT: Ali 

Salimi by telephone at (571) 272–0909; 

by mail marked to his attention and 

addressed to the Commissioner for 

Patents, Mail Stop Hatch-Waxman PTE, 

P.O. Box 1450, Alexandria, VA 22313– 

1450; by fax marked to his attention at 

(571) 273–0909; or by email to 

ali.salimi@uspto.gov. 

SUPPLEMENTARY INFORMATION: Section 

156 of Title 35, United States Code, 

generally provides that the term of a 

patent may be extended for a period of 

up to five years if the patent claims a 

product, or a method of making or using 

a product, that has been subject to 

certain defined regulatory review, and 

that the patent may be extended for 

interim periods of up to one year if the 

regulatory review is anticipated to 

extend beyond the expiration date of the 

patent. 

On April 8, 2022, Neovasc Medical 

Ltd., the patent owner of record, timely 

filed an application under 35 U.S.C. 

156(d)(5) for a third interim extension of 

the term of U.S. Patent No. 9,364,354. 

The patent claims the catheter 

implantable device, Reducer®. The 

application for patent term extension 

indicates that a Premarket Approval 

Application (PMA) P190035 was 

submitted to the Food and Drug 

Administration (FDA) on December 31, 

2019. 

Review of the patent term extension 

application indicates that, except for 

permission to market or use the product 

commercially, the subject patent would 

be eligible for an extension of the patent 

term under 35 U.S.C. 156, and that the 

patent should be extended for one year 

as required by 35 U.S.C. 156(d)(5)(B). 

Because there is a reasonable 

expectation that the regulatory review 

period will continue beyond the twiceextended expiration date of the patent, 

June 6, 2022, a third interim extension 

of the patent term under 35 U.S.C. 

156(d)(5) is appropriate. 

A third interim extension under 35 

U.S.C. 156(d)(5) of the term of U.S. 

Patent No. 9,364,354 is granted for a 

period of one year from the twiceextended expiration date of the patent. 

Robert Bahr, 

Deputy Commissioner for Patents, United 

States Patent and Trademark Office. 

[FR Doc. 2022–08492 Filed 4–20–22; 8:45 am] 

BILLING CODE 3510–16–P 

COMMODITY FUTURES TRADING 

COMMISSION 

Renewal of the Market Risk Advisory 

Committee 

AGENCY: Commodity Futures Trading 

Commission. 

ACTION: Notice of renewal. 

SUMMARY: The Commodity Futures 

Trading Commission (Commission) is 

publishing this notice to announce the 

renewal of the Market Risk Advisory 

Committee (MRAC). The Commission 

has determined that the renewal of the 

MRAC is necessary and in the public’s 

interest, and the Commission has 

consulted with the General Services 

Administration’s Committee 

Management Secretariat regarding the 

MRAC’s renewal. 

FOR FURTHER INFORMATION CONTACT: 

Alicia Lewis, MRAC Designated Federal 

Officer, at 202–418–5862 or alewis@

cftc.gov. 

SUPPLEMENTARY INFORMATION: In support 

of the Commission’s mission of 

promoting the integrity, resilience, and 

vibrancy of the U.S. derivatives markets 

through sound regulation as well as the 

monitoring and management of systemic 

risk, the MRAC’s objectives and scope of 

activities are to conduct public 

meetings, advise, and submit reports 

and recommendations to the 

Commission on: (1) Systemic issues that 

impact the stability of the derivatives 

markets and other related financial 

markets; and (2) the impact and 

implications of the evolving market 

structure of the derivatives markets and 

other related financial markets. The 

MRAC will operate for two years from 

the date of renewal unless the 

Commission directs that the MRAC 

terminate on an earlier date. A copy of 

the renewal charter will be posted on 

the Commission’s website at 

www.cftc.gov. 

Dated: April 18, 2022. 

Christopher Kirkpatrick, 

Secretary of the Commission. 

[FR Doc. 2022–08540 Filed 4–20–22; 8:45 am] 

BILLING CODE 6351–01–P 

DEPARTMENT OF DEFENSE 

Office of the Secretary 

Renewal of Department of Defense 

Federal Advisory Committees— 

Defense Innovation Board 

AGENCY: Department of Defense (DoD). 

ACTION: Renewal of Federal Advisory 

Committee. 

SUMMARY: The DoD is publishing this 

notice to announce that it is renewing 

the Defense Innovation Board (DIB). 

FOR FURTHER INFORMATION CONTACT: Jim 

Freeman, DoD Advisory Committee 

Management Officer, 703–692–5952. 

SUPPLEMENTARY INFORMATION: The DIB is 

being renewed in accordance with the 

Federal Advisory Committee Act 

(FACA) (5 U.S.C., appendix) and 41 CFR 

102–3.50(d). The charter and contact 

information for the DIB’s Designated 

Federal Officer (DFO) are found at 

https://www.facadatabase.gov/FACA/ 

apex/FACAPublicAgencyNavigation. 

The DIB provides the Secretary of 

Defense and Deputy Secretary of 

Defense with independent advice and 

recommendations to address challenges 

and accelerate innovation adoption into 

the culture, technologies, organizational 

structures, processes, and functions of 

the DoD. The DIB shall focus on 

innovative means to address future 

challenges and accelerate innovation 

adoption into the culture, technologies, 

organizational structures, processes, and 

any other topics raised by the Secretary 

of Defense or the Deputy Secretary of 

Defense (‘‘the DoD Appointing 

Authority’’) or the Under Secretary of 

Defense for Research and Engineering 

(USD(R&E)) unless otherwise provided 

for by statute or Presidential directive. 

The DIB is composed of no more than 

20 members must possess some or all of 

the following: (a) A proven track record 

of sound judgment in leading or 

governing large, complex private sector 

corporations or organizations; (b) 

demonstrated performance in 

identifying and adopting new 

technology innovations into the 

operations of large organizations in 

either the public or private sector; (c) 

demonstrated performance in 


jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 77 / Thursday, April 21, 2022 / Notices 23859 

developing new technology concepts; 

and (d) a proven track record as a 

distinguished academic or researcher at 

an accredited college or institute of 

higher education. Members will consist 

of talented, innovative leaders with a 

diversity of background, experience, 

and thought in support of the DIB 

missions. 

Individual members are appointed 

according to DoD policy and 

procedures, and serve a term of service 

of one-to-four years with annual 

renewals. One member will be 

appointed as Chair of the DIB. No 

member, unless approved according to 

DoD policy and procedures, may serve 

more than two consecutive terms of 

service on the DIB, or serve on more 

than two DoD Federal advisory 

committees at one time. 

DIB members who are not full-time or 

permanent part-time Federal civilian 

officers or employees, or active duty 

members of the Uniformed Services, 

shall be appointed as experts or 

consultants pursuant to 5 U.S.C. 3109 to 

serve as special government employee 

members. DIB members who are fulltime or permanent part-time civilian 

officers or employees, or active duty 

members of the Uniformed Services, 

shall be appointed pursuant to 41 CFR 

102–3.130(a) to serve as regular 

employee members. 

All members of the DIB are appointed 

to exercise their own best judgment, 

without representing any particular 

point of view, and to discuss and 

deliberate in a manner that is free from 

conflict of interest. Except for 

reimbursement of official DIB-related 

travel and per diem, members serve 

without compensation. 

The public or interested organizations 

may submit written statements about 

the DIB’s mission and functions. 

Written statements may be submitted at 

any time or in response to the stated 

agenda of planned meeting of the DIB. 

All written statements shall be 

submitted to the DFO for the DIB, and 

this individual will ensure that the 

written statements are provided to the 

membership for their consideration. 

Dated: April 15, 2022. 

Aaron T. Siegel, 

Alternate OSD Federal Register Liaison 

Officer, Department of Defense. 

[FR Doc. 2022–08485 Filed 4–20–22; 8:45 am] 

BILLING CODE 5001–06–P 

DEPARTMENT OF DEFENSE 

Office of the Secretary 

Defense Business Board; Notice of 

Federal Advisory Committee Meeting 

AGENCY: Office of the Deputy Secretary 

of Defense, Department of Defense 

(DoD). 

ACTION: Notice of Federal Advisory 

Committee meeting. 

SUMMARY: The DoD is publishing this 

notice to announce that the following 

Federal Advisory Committee meeting of 

the Defense Business Board (‘‘the 

Board’’) will take place. 

DATES: Closed to the public Wednesday, 

May 11, 2022 from 6:00 p.m. to 7:30 

p.m. Closed to the public Thursday, 

May 12, 2022 from 9:15 a.m. to 1:00 

p.m. Open to the public Thursday, May 

12, 2022 from 1:00 p.m. to 4:20 p.m. All 

Eastern time. 

ADDRESSES: The open and closed 

portions of the meeting will be in 

Rooms 4D880 and 4E869 in the 

Pentagon, Washington, DC. Due to the 

current guidance on combating the 

Coronavirus, the public portions of the 

meeting will be conducted by 

teleconference only. To participate in 

the open portion of the meeting, see the 

Meeting Accessibility section for 

instructions. 

FOR FURTHER INFORMATION CONTACT: Ms. 

Jennifer Hill, Designated Federal Officer 

of the Board in writing at Defense 

Business Board, 1155 Defense Pentagon, 

Room 5B1088A, Washington, DC 

20301–1155; or by email at 

jennifer.s.hill4.civ@mail.mil; or by 

phone at 571–342–0070. 

SUPPLEMENTARY INFORMATION: This 

meeting is being held under the 

provisions of the Federal Advisory 

Committee Act (FACA) (5 U.S.C., 

appendix), the Government in the 

Sunshine Act (5 U.S.C. 552b), and 41 

CFR 102–3.140 and 102–3.150. 

Purpose of the Meeting: The mission 

of the Board is to examine and advise 

the Secretary of Defense on overall DoD 

management and governance. The Board 

provides independent, strategic-level, 

private sector and academic advice and 

counsel on enterprise-wide business 

management approaches and best 

practices for business operations and 

achieving National Defense goals. 

Agenda: The Board meeting will 

begin in closed session on May 11, 2022 

from 6:00 p.m. to 7:30 p.m. Eastern time 

with opening remarks by Ms. Jennifer 

Hill, the Designated Federal Officer, 

followed by a classified briefing from 

Mr. Mike Brown, Director, Defense 

Innovation Unit, on rapid access and 

adoption of commercial technologies for 

the DoD that strengthen the national 

security innovation base. The Board will 

reconvene in closed session on May 12, 

2022 at 9:15 a.m. Eastern time with 

opening remarks by Ms. Jennifer Hill, 

the Designated Federal Officer. The 

Board will then receive classified 

remarks on the DoD budget with respect 

to the National Defense Strategy from 

the Hon. Kathleen Hicks, Deputy 

Secretary of Defense, followed by a 

classified briefing from the Hon. John 

Sherman, DoD Chief Information Officer 

on the current state of DoD IT. The 

Board will then receive a classified 

briefing from Mr. James Baker, Director, 

Office of Net Assessment (ONA), on 

ONA’s current assessment of global 

competition and strategic challenges for 

DoD. The meeting will move into open 

session beginning at 1:00 p.m. to receive 

a presentation by Ms. Linnie 

Haynesworth, Chair, Business 

Transformation Advisory Subcommittee 

on the ‘‘Executive Analytics for Defense 

Business Operations’’ study and a 

presentation by General Larry Spencer, 

USAF (Ret), Chair, Talent Management, 

Culture, & Diversity Advisory 

Subcommittee on the ‘Reskilling/ 

Upskilling Career DoD Civilians in New 

and Emerging Technologies’ study. The 

Board members will deliberate and vote 

on the proposed findings, observations, 

and recommendations from both 

studies. The meeting will conclude with 

closing remarks by the Designated 

Federal Officer. The latest version of the 

agenda will be available on the Board’s 

website at: https://dbb.defense.gov/ 

Meetings/Meeting-May12-2022/. 

Meeting Accessibility: In accordance 

with Section 10(d) of the FACA and 41 

CFR 102–3.155, it is hereby determined 

that portions of the May 11–12, 2022 

meeting of the Board will include 

classified information and other matters 

covered by 5 U.S.C. 552b(c)(1) and that, 

accordingly, the meeting will be closed 

to the public on May 11, 2022 from 6:00 

p.m. to 7:30 p.m. and on May 12, 2022 

from 9:15 a.m. to 1:00 p.m. This 

determination is based on the 

consideration that it is expected that 

discussions throughout these periods 

will involve classified matters of 

national security. Such classified 

material is so intertwined with the 

unclassified material that it cannot 

reasonably be segregated into separate 

discussions without defeating the 

effectiveness and meaning of these 

portions of the meeting. To permit these 

portions of the meeting to be open to the 

public would preclude discussion of 

such matters and would greatly 


jspears on DSK121TN23PROD with NOTICES1